Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 117.80
+2.60 (2.26%)
Nov 4, 2026, 5:29 PM CET
Vitrolife AB Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vitrolife AB stock has a consensus rating of "Buy" and an average price target of kr 133.00. The average 1-year stock price forecast is 12.90% higher than the current stock price, while the lowest is kr 105.00 (-10.87%) and the highest is kr 155.00 (+31.58%).
Price Target: kr 133.00 (+12.90%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vitrolife AB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
3.51B
from 3.44B
Increased by 2.07%
Revenue Next Year
3.83B
from 3.51B
Increased by 9.00%
EPS This Year
4.56
from 2.89
Increased by 57.65%
EPS Next Year
5.52
from 4.56
Increased by 21.15%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.